No insider purchase over the last 90 days. The latest was filed 03 Mar 2022.
We have very little insider data for AlerisLife Inc. so far: the most recent filing dates from 20 March 2023. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2021 · cache
25 of 43 declarations
AlerisLife Inc. is a company focused on the health and pharmaceutical sector. It concentrates on developing innovative solutions to enhance patients' quality of life.
Purchases our model currently ranks for the recommendations list.
All recommendations